Satellos Bioscience Inc. (MSCLF) Form 6-K — May 20, 2026
Satellos Bioscience Inc. filed an Information Circular for its annual meeting of shareholders, detailing executive compensation and recent capital raises. The filing serves as the proxy statement for the virtual annual meeting scheduled for May 2026. CEO Frank Gleeson received total compensation of approximately $1.97 million in 2025, driven largely by option-based awards valued at $1.32 million.
Key figures
- Ceo Compensation
- 1974344
- Gross Proceeds2024
- 57000000
- Gross Proceeds2026
- 57200000
- Offering Price2026
- 10.1
- Shares Offered2026
- 5168019
- Cfo Compensation
- 934170
- Cmocompensation
- 945460
- Csocompensation
- 1073356
- Exec Comp Fees2024
- 41709
- Exec Comp Fees2025
- 67606
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.